Regenxbio (RGNX) EBIT Margin Growth (5y) (2019 - 2025)
Regenxbio (RGNX) EBIT Margin Growth (5y) (2019 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
| 10 |
Regenxbio |
325.94 Mn |
95.87 Mn |
- |
| Date | Value |
|---|
| Dec 31, 2025 |
6,019.00 |
| Sep 30, 2025 |
-19,038.00 |
| Jun 30, 2025 |
-4,374.00 |
| Mar 31, 2025 |
22,729.00 |
| Dec 31, 2024 |
10,052.00 |
| Sep 30, 2024 |
-1,236.00 |
| Jun 30, 2024 |
21,652.00 |
| Mar 31, 2024 |
365,296.00 |
| Dec 31, 2023 |
-13,125.00 |
| Sep 30, 2023 |
20,362.00 |
| Jun 30, 2023 |
-38,182.00 |
| Mar 31, 2023 |
-42,275.00 |
| Dec 31, 2022 |
62,932.00 |
| Sep 30, 2022 |
132,701.00 |
| Jun 30, 2022 |
3,791.00 |
| Mar 31, 2022 |
471,587.00 |
| Dec 31, 2021 |
128,556.00 |
| Sep 30, 2021 |
1.47 Mn |
| Jun 30, 2021 |
39,254.00 |
| Mar 31, 2021 |
262,963.00 |
